Breaking News on Contract Research, Manufacturing & Clinical Trials

Avista supporting cGMP manufacture of hapten for opioid vaccine development

26-Jun-2017 - Avista Pharma Solutions, Inc. has been contracted to manufacture an opioid-derived small molecule, which is a component of a conjugate vaccine being developed to treat opioid addiction.

Baxter hires Indian contractor to expand injectables pipeline

22-Jun-2017 - Baxter International has announced an agreement with India-based Dorizoe Lifesciences to develop over 20 generic injectables, a sector it says is growing annually.

Label concept combines first-opening indication, blinding for clinical trials

19-Jun-2017 - Schreiner MediPharm’s new Flexi-Cap for Clinical Trial Supplies provides anti-counterfeit protection with blinding for transparent containers.


Continuous manufacturing process 'well-placed and capable,' says CEO

07-Jun-2017 - Teams of engineers at CordenPharma and Acasti Pharma came together to develop a proprietary continuous manufacturing process – which simplifies scale up and process re-validation.

AMRI set to be acquired by private equity

06-Jun-2017 - Private equity continues to make inroads in the contract research industry with two firms set to purchase AMRI in a deal worth $21.75 per share.

Acasti and CordenPharma look to continuous production for omega-3 drug

06-Jun-2017 - Continuous manufacturing equipment installed at a CordenPharma French facility has reduced cycle time and cost of making a hypertriglyceridemia drug, says Acasti Pharma.

Patheon to manufacture amyloidosis antibody treatment for Caelum

02-Jun-2017 - Caelum Biosciences has selected Patheon to make its lead antibody CAEL-101 to treat orphan disease amyloid light-chain (AL) amyloidosis.

Cambrex continues to up capacity with more than $200m invested in 5 years

31-May-2017 - Cambrex Corporation has increased new capacity at its Sweden-based cGMP as the manufacturer focuses on market demand and customer need, says VP.

People on the move

Outsourcing-Pharma's Hiring and Firing Roundup May '17

31-May-2017 - This month’s roundup includes new executive leadership teams, hires on both sides of the Atlantic for CRO Smithers Viscient, a new VP and medical director at Clinipace, among others....

Hovione launches first clinical trial, more to come

25-May-2017 - Hovione has launched its first clinical trial and has already set sights on a second as the CDMO hopes to establish licensing partnership with pharma, says VP.

LSNE tapped for drug substance manufacturing, fill/finish services

25-May-2017 - LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, Inc. through which the CDMO will advance Selecta’s lead candidate, SEL-212.

CDMO Recro expands manufacturing capabilities at former Alkermes site

24-May-2017 - Recro has added a new tablet manufacturing suite that enables it to compress single- and bi-layer tablets at commercial speeds.

CPhI North America

Cambrex invests $2.4m at former PharmaCore site

17-May-2017 - Cambrex Corporation is installing a fourth reactor suite at its High Point, NC-based facility as it continues to grow with its customers in the market, says company VP at CPhI North America....

Thermo Fisher: $7.2bn Patheon sits in sweet spot for bioproduction business

17-May-2017 - Thermo Fisher says Patheon will become the most competitive biologics CDMO in the market through direct access to its bioprocessing technologies and capabalities.

Family-owned Flamma opens $20m cGMP facility in China

16-May-2017 - Flamma has opened a new cGMP workshop and R&D Center in Dalian, China and is looking to add capacity at several other sites as part of its “Flamma 2020 plan.”...

Avantor to spend $6.4bn on VWR acquisition

12-May-2017 - Avantor has agreed to purchase independent laboratory product, supply chain and service provider VWR for approximately $6.4bn (€5.9bn), reflecting a share price of $33.25.

Aptar Pharma continues its North American expansion

11-May-2017 - Aptar Pharma has acquired 20% of the US-based company, Kali Care, less than two months after inaugurating its first facility outside of France as it aims to expand globally. 

CMO sector still set for consolidation says industry expert

11-May-2017 - Mergers and acquisitions remain a key growth strategy for contract manufacturing organizations (CMOs) as uncertainly persists across the industry. 

Brammer invests in commercial-ready gene therapies

10-May-2017 - Brammer Bio says its commercial-scale gene therapy manufacturing facility in Cambridge, Massachusetts, US, will open in the second half of 2017.

Shire using Baxalta network to bring 30% Cinryze production in-house

05-May-2017 - Shire has begun adding capability within its own network to manufacture the Hereditary Angioedema (HAE) product Cinryze, currently being made by Dutch CMO Sanquin.

BioMarin defends US FDA-approved Brineura’s $702k price tag

04-May-2017 - Brineura's $702,000 (€640,000) a-year price tag reflects production costs and investment in tech used to administer the enzyme replacement therapy to the brain says BioMarin Pharmaceuticals.

PharmaCell to make autologous cell therapies for Lion Biotech

28-Apr-2017 - Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.

Recipharm invests $750k in new GMP suite

27-Apr-2017 - Recipharm has opened a new GMP suite for clinical trial material manufacture at its North Carolina-based facility in Research Triangle Park.

Solubility solutions: Catalent increases spray drying capacity at Pharmatek

27-Apr-2017 - Catalent Pharma Solutions is increasing cGMP spray drying capacity at its Pharmatek facility in response to industry demand for improved solubility.

EAG expanding bioassay lab, adding new staff

26-Apr-2017 - EAG Laboratories is expanding its Columbia, Missouri-based cell bioassay laboratory to support multiple development programs.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...